VIMTALABS logo

Vimta LABS Limited

VIMTALABS·NSE·
656.80 -4.95 (-0.75%)
Market Cap2928.56 Cr
PE Ratio37.86
Volume2,70,018
Day High - Low666.65 - 644.00
52W High-Low902.65 - 376.05
DocStoX Score
6.5/10
Fair
Fair Value
Sign in to see
ROE
17.07%
Strong
P/E
37.86x
Expensive
Debt / Equity
0.01
Low
Industry
Healthcare
Healthcare Research, Analytics & Technology
Overall View
Mixed

Price performance

Day644.00
666.65
52W376.05
902.65
DocStoX take

Supported by growth (8.8) and quality (8.5), but held back by valuation (1.1). Growth looks strong at 8.8, but that is offset by valuation at 1.1. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.5
/10
Fair
Quality
Excellent
ROE 17.1%
Valuation
Expensive
P/E 37.9×
Growth
Strong
Revenue +14.3% 5Y CAGR
Risk
Low risk
D/E 0.01
Momentum
Firm
53% of 52-week range

At a glance

Market Cap
₹2,929 Cr
52W High / Low
₹903 / ₹376
Dividend Yield
0.33%
Promoter Holding
35.67%
EPS (TTM)
₹17.35
Book Value
₹101.65

Key highlights

  • Low leverage — D/E 0.01
  • Profit compounding 30% a year
  • Profitable in all of the last 5 years
  • Valuation is weak (1.1/10)
4 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Research, Analytics & Technology

VIMTA LABS LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.